Skip to main content

Tina Woods

Theme: Raising potential influence
Topic: Quantum Healthy Longevity: Optimising Human Healthspan and Resilience From Cells to Cities
Date/Time: Aug 19 @5:00 PM
Healthy Longevity Champion, Social Entrepreneur and System Architect in Preventative Health and Open Health Data/AI.

Tina Woods is a mission-driven social entrepreneur and system architect bringing diverse stakeholders together in shared endeavours to improve and level up health, working at the cross section of science, technology, investment and policy/government. She is Founder and CEO of Collider Health and works with private, public and third sectors, including UK Research and Innovation (UKRI)’s Healthy Ageing Industrial Strategy, NHS AI Lab, and emerging Integrated Care Systems.

She is the Healthy Longevity Champion for the National Innovation Centre for Ageing, aiming to accelerate ageing intelligence and secure UK Research & Innovation’s strategic aims to ensure better health, ageing and wellbeing in the UK and globally. She is co-leading the Quantum Healthy Longevity Innovation Mission with the National Innovation Centre for Ageing to create the world’s first test bed for health underpinned by growing understanding of the exposome and links between health and climate.

Tina was director of the All Party Parliamentary Group for Longevity secretariat until it disbanded in January 2023, and led the Open Life Data Framework. She is Co-Founder and CEO of Business for Health, a business-led social venture developing a Business Framework for Health, bringing in ‘Health’ into ‘ESG’ mandates to support long-term sustainable innovation and investment in preventative health and care. Tina’s book, ‘Live Longer with AI: How artificial intelligence is helping us extend our healthspans and live better too’ was published in October 2020.

Tina sits on various advisory groups, including the Strategic Advisory Board for the BBRSC Bioscience for an Integrated Understanding of Health, BSI standards group for AI in health and care, and the Ada Lovelace Advisory Board on Health Inequalities. She is also a trustee for the British Society for Research on Ageing.

She studied genetics at Cornell University in the USA and also has an MBA from Bayes Business School (formerly Cass/City).